Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd.
Clinical trials sponsored by Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd., explained in plain language.
-
New Weight-Loss shot shows promise in early trial
Disease control CompletedThis study tested a new medicine called CPX101 to help overweight and obese people lose weight. About 240 adults without diabetes took part. The goal was to see if the drug is safe and effective for weight loss over 24 weeks.
Phase: PHASE2 • Sponsor: Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC
-
New Weight-Loss drug CPX101 enters early human testing
Symptom relief CompletedThis early-stage study tested a new drug called CPX101 in 72 healthy volunteers and overweight or obese patients. The main goal was to see if the drug is safe and tolerable, and to measure how it moves through the body. Researchers also looked at whether multiple doses could help…
Phase: PHASE1 • Sponsor: Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 02, 2026 16:45 UTC